Shareholders Equity: The sum of preferred and common equity items.
Psyence Biomedical Ltd. (PBM) had Shareholders Equity of $-1.26M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$0.14M |
|
-- |
|
-- |
|
$1.16M |
|
$-1.16M |
|
$1.30M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$-1.16M |
|
$-1.16M |
|
0.03M |
|
0.03M |
|
$4.13 |
|
$4.05 |
|
| Balance Sheet Financials | |
$2.24M |
|
$0.01M |
|
$0.01M |
|
$2.25M |
|
$3.51M |
|
-- |
|
-- |
|
$3.51M |
|
$-1.26M |
|
$-1.26M |
|
|
Shareholders Equity |
$-1.26M |
0.08M |
|
| Cash Flow Statement Financials | |
$-1.52M |
|
$-0.01M |
|
$2.72M |
|
$0.73M |
|
$1.93M |
|
$1.20M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-- |
|
-0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.27% |
|
-11.27% |
|
6.28% |
|
-11.27% |
|
$-16.47 |
|
$-43.72 |
|
$-43.53 |
|